Modulation of innate immune signaling by the secreted form of the West Nile virus NS1 glycoprotein

Virology

Volumn 458-459, Issue 1, 2014, Pages 172-182

  Crook, Kristen R ^a   Miller Kittrell, Mindy ^a   Morrison, Clayton R ^a   Scholle, Frank ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Flaviviridae; Innate immunity; Nonstructural protein; Toll like receptor; West Nile virus

Indexed keywords

CARBOXYMETHYLCELLULOSE POLYCYTIDYLIC POLYINOSINIC ACID POLYLYSINE; NONSTRUCTURAL PROTEIN 1; TOLL LIKE RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EMBRYO; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LYMPH NODE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PURIFICATION; PROTEIN SECRETION; REPLICON; SIGNAL TRANSDUCTION; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

FLAVIVIRIDAE; INNATE IMMUNITY; NONSTRUCTURAL PROTEIN; TOLL LIKE RECEPTOR; WEST NILE VIRUS;

ANIMALS; HELA CELLS; HUMANS; IMMUNITY, INNATE; LUCIFERASES; MACROPHAGES; MICE; MICE, INBRED C57BL; MYELOID CELLS; POLY I-C; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; TOLL-LIKE RECEPTOR 3; VIRAL NONSTRUCTURAL PROTEINS; WEST NILE VIRUS;

EID: 84900399883     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.04.036     Document Type: Article

References (45)

1. Alcon-LePoder S., Drouet M.T., Roux P., Frenkiel M.P., Arborio M., Durand-Schneider A.M., Maurice M., Le Blanc I., Gruenberg J., Flamand M. The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity. J. Virol. 2005, 79(17):11403-11411.
2. Arjona A., Ledizet M., Anthony K., Bonafe N., Modis Y., Town T., Fikrig E. West Nile virus envelope protein inhibits dsRNA-induced innate immune responses. J. Immunol. 2007, 179(12):8403-8409.
3. Avirutnan P., Fuchs A., Hauhart R.E., Somnuke P., Youn S., Diamond M.S., Atkinson J.P. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J. Exp. Med. 2010, 207(4):793-806.
4. Avirutnan P., Hauhart R.E., Somnuke P., Blom A.M., Diamond M.S., Atkinson J.P. Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation. J. Immunol. 2011, 187(1):424-433.
5. Avirutnan P., Zhang L., Punyadee N., Manuyakorn A., Puttikhunt C., Kasinrerk W., Malasit P., Atkinson J.P., Diamond M.S. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog. 2007, 3(11):e183.
6. Baronti C., Sire J., de Lamballerie X., Querat G Nonstructural NS1 proteins of several mosquito-borne Flavivirus do not inhibit TLR3 signaling. Virology 2010, 404(2):319-330.
7. Bourne N., Scholle F., Silva M.C., Rossi S.L., Dewsbury N., Judy B., De Aguiar J.B., Leon M.A., Estes D.M., Fayzulin R., Mason P.W. Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production. J. Virol. 2007, 81(17):9100-9108.
8. Brown A.N., Kent K.A., Bennett C.J., Bernard K.A. Tissue tropism and neuroinvasion of West Nile virus do not differ for two mouse strains with different survival rates. Virology 2007, 368(2):422-430.
9. Byrne S.N., Halliday G.M., Johnston L.J., King N.J.C. Interleukin-1beta but not tumor necrosis factor is involved in West Nile Virus-induced Langerhans cell migration from the skin in C57BL/6 mice. J. Invest. Dermatol. 2001, 117(3):702-709.
10. Caskey M., Lefebvre F., Filali-Mouhim A., Cameron M.J., Goulet J.P., Haddad E.K., Breton G., Trumpfheller C., Pollak S., Shimeliovich I., Duque-Alarcon A., Pan L., Nelkenbaum A., Salazar A.M., Schlesinger S.J., Steinman R.M., Sekaly R.P. Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. J. Exp. Med. 2011, 208(12):2357-2366.
11. Chung K.M., Diamond M.S. Defining the levels of secreted non-structural protein NS1 after West Nile virus infection in cell culture and mice. J. Med. Virol. 2008, 80(3):547-556.
12. Chung K.M., Liszewski M.K., Nybakken G., Davis A.E., Townsend R.R., Fremont D.H., Atkinson J.P., Diamond M.S. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc. Nat. Acad. Sci. U.S.A. 2006, 103(50):19111-19116.
13. Daffis S., Samuel M.A., Suthar M.S., Gale M., Diamond M.S. Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol. 2008, 82(21):10349-10358.
14. Diebold S.S., Kaisho T., Hemmi H., Akira S., Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303(5663):1529-1531.
15. Duthie M.S., Windish H.P., Fox C.B., Reed S.G. Use of defined TLR ligands as adjuvants within human vaccines. Immunol. Rev. 2011, 239(1):178-196.
16. Flamand M., Megret F., Mathieu M., Lepault J., Rey F.A., Deubel V. Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J. Virol. 1999, 73(7):6104-6110.
17. Fredericksen B.L., Gale M. West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J. Virol. 2006, 80(6):2913-2923.
18. Fredericksen B.L., Keller B.C., Fornek J., Katze M.G., Gale M. Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J. Virol. 2008, 82(2):609-616.
19. Fredericksen B.L., Smith M., Katze M.G., Shi P.Y., Gale M. The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway. J. Virol. 2004, 78(14):7737-7747.
20. Fuchs A., Lin T.Y., Beasley D.W., Stover C.M., Schwaeble W.J., Pierson T.C., Diamond M.S. Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin. Cell Host Microb. 2010, 8(2):186-195.
21. Fuchs A., Pinto A.K., Schwaeble W.J., Diamond M.S. The lectin pathway of complement activation contributes to protection from West Nile virus infection. Virology 2011, 412(1):101-109.
22. Johnston L.J., Halliday G.M., King N.J. Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus. J. Invest. Dermatol. 2000, 114(3):560-568.
23. Kawai T., Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann. N.Y. Acad. Sci. 2008, 1143:1-20.
24. Khromykh A.A., Sedlak P.L., Guyatt K.J., Hall R.A., Westaway E.G. Efficient trans-complementation of the flavivirus Kunjin NS5 protein but not of the NS1 protein requires its coexpression with other components of the viral replicase. J. Virol. 1999, 73(12):10272-10280.
25. Lim P.Y., Behr M.J., Chadwick C.M., Shi P.Y., Bernard K.A. Keratinocytes are cell targets of West Nile virus in vivo. J. Virol. 2011, 85(10):5197-5201.
26. Lindenbach B.D., Rice C.M. trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J. Virol. 1997, 71(12):9608-9617.
27. Loo Y.M., Fornek J., Crochet N., Bajwa G., Perwitasari O., Martinez-Sobrido L., Akira S., Gill M.A., Garcia-Sastre A., Katze M.G., Gale M. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 2008, 82(1):335-345.
28. Lund J.M., Alexopoulou L., Sato A., Karow M., Adams N.C., Gale N.W., Iwasaki A., Flavell R.A. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Nat. Acad. Sci. U.S.A. 2004, 101(15):5598-5603.
29. Macdonald J., Tonry J., Hall R.A., Williams B., Palacios G., Ashok M.S., Jabado O., Clark D., Tesh R.B., Briese T., Lipkin W.I. NS1 protein secretion during the acute phase of West Nile virus infection. J. Virol. 2005, 79(22):13924-13933.
30. Mason P.W., Shustov A.V., Frolov I. Production and characterization of vaccines based on flaviviruses defective in replication. Virology 2006, 351(2):432-443.
31. Nasirudeen A.M., Wong H.H., Thien P., Xu S., Lam K.P., Liu D.X. RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl.Trop. Dis. 2011, 5(1):e926.
32. Scholle F., Mason P.W. West Nile virus replication interferes with both poly(I:C)-induced interferon gene transcription and response to interferon treatment. Virology 2005, 342(1):77-87.
33. Silva M.C., Guerrero-Plata A., Gilfoy F.D., Garofalo R.P., Mason P.W. Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cells. J. Virol. 2007, 81(24):13640-13648.
34. Town T., Bai F., Wang T., Kaplan A.T., Qian F., Montgomery R.R., Anderson J.F., Flavell R.A., Fikrig E. Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity 2009, 30(2):242-253.
35. Tsai Y.T., Chang S.Y., Lee C.N., Kao C.L. Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cell. Microbiol. 2009, 11(4):604-615.
36. Wang J.P., Liu P., Latz E., Golenbock D.T., Finberg R.W., Libraty D.H. Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition. J. Immunol. 2006, 177(10):7114-7121.
37. Wang T., Town T., Alexopoulou L., Anderson J.F., Fikrig E., Flavell R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 2004, 10(12):1366-1373.
38. Welte T., Reagan K., Fang H., Machain-Williams C., Zheng X., Mendell N., Chang G.J., Wu P., Blair C.D., Wang T. Toll-like receptor 7-induced immune response to cutaneous West Nile virus infection. J. Gen. Virol. 2009, 90(Pt 11):2660-2668.
39. Westaway E.G., Mackenzie J.M., Kenney M.T., Jones M.K., Khromykh A.A. Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures. J. Virol. 1997, 71(9):6650-6661.
40. Wilson J.R., de Sessions P.F., Leon M.A., Scholle F. West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. J. Virol. 2008, 82(17):8262-8271.
41. Wu S.J.L., Grouard V.G., Sun W., Mascola J.R., Brachtel E., Putvatana R., Louder M.K., Filgueira L., Marovich M.A., Wong H.K., Blauvelt A., Murphy G.S., Robb M.L., Innes B.L., Birx D.L., Hayes C.G., Schlesinger F.S. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 2000, 6(7):816-820.
42. Xia J., Winkelmann E.R., Gorder S.R., Mason P.W., Milligan G.N. TLR3- and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidate. J. Virol. 2013, 87(22):12090-12101.
43. Youn S., Cho H., Fremont D.H., Diamond M.S. A short N-terminal peptide motif on flavivirus nonstructural protein NS1 modulates cellular targeting and immune recognition. J. Virol. 2010, 84(18):9516-9532.
44. Youn S., Li T., McCune B.T., Edeling M.A., Fremont D.H., Cristea I.M., Diamond M.S. Evidence for a genetic and physical interaction between nonstructural proteins NS1 and NS4B that modulates replication of West Nile Virus. J. Virol. 2012, 86(13):7360-7371.
45. Young P.R., Hilditch P.A., Bletchly C., Halloran W. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J. Clin. Microbiol. 2000, 38(3):1053-1057.